Results 131 to 140 of about 4,182 (143)

Which type of vaccine is more beneficial for reducing the risk of deep vein thrombosis, CoronaVac, BNT162b2, or TURKOVAC? [PDF]

Sci Prog
Yazıcı S, Beyazal OF, Tezcan H.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Local reactions to the second dose of the BNT162 COVID ‐19 vaccine

Dermatologic Therapy, 2021
Antonella Tammaro, Ganiyat Adenike Ralitsa Adebanjo, Francesca Romana Parisella   +2 more
exaly  

Myocarditis After BNT162b2 COVID-19 Third Booster Vaccine in Israel

Circulation, 2022
Dror Mevorach, Michal Bromberg, Ofer Perzon   +2 more
exaly  

Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex

Circulation, 2022
Martina Patone, Xue W Mei, Lahiru Handunnetthi   +2 more
exaly  

Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic

Journal of Clinical Medicine, 2021
Abanoub Riad, Andrea Pokorna, Sameh Attia   +2 more
exaly  

Myocarditis After BNT162b2 and mRNA-1273 Vaccination

Circulation, 2021
Kathryn F Larson, Enrico Ammirati, Eric Adler   +2 more
exaly  

Humoral Response to BNT162b2 mRNA SARS-CoV-2 Vaccine in Patients with Nondialysis Chronic Kidney Disease

Clinical Journal of the American Society of Nephrology: CJASN, 2021
Lucile Figueres
exaly  

Assessment of Post-Vaccination Antibody Response Eight Months after the Administration of BNT1622b2 Vaccine to Healthcare Workers with Particular Emphasis on the Impact of Previous COVID-19 Infection

Vaccines, 2021
Blanka Wolszczak-Biedrzycka, Justyna Zinczuk   +1 more
exaly  

Cutaneous adverse reactions following the Pfizer/BioNTech COVID‐19 vaccine

Australasian Journal of Dermatology, 2022
Anna Luo, Amanda Oakley
exaly